Results may vary from person to person based on these factors
So, heres what I tell them
In children, the possibility of a genodermatosis should be considered (e.g., Peutz-Jeghers syndrome, Dowling-Degos disease)
In 2009, Novo Nordisk's Liraglutide (Victoza) was approved by the EMA and in January 2010 by the FDA for the treatment of type 2 diabetes
It is the only one with decades of clinical research behind it
Most clinical assays only measure total platinum levels, while the toxicological activity varies drastically among platinum species with distinct chemical forms (e.g., inert complexes bound to GSH, MT, and methionine), leading to inaccurate assessment of accumulation-related toxicity risk